Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Recombinant Human minibody against complement component C5 fused with RGD-motif

EU orphan designation number: EU/3/08/604   
Active ingredient: Recombinant Human minibody against complement component C5 fused with RGD-motif
Indication: Prevention of the ischemia/reperfusion injury associated with solid organ transplantation
Sponsor: ADIENNE S.r.l.
Via Galileo Galilei 19, 20867 Caponago (MB), Italia

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
22/01/2009 Orphan designation EMEA/OD/047/08 (2009)423 of 20/01/2009
15/01/2014 Change of name and/or address of sponsor